Have a personal or library account? Click to login
Dosimetric Outcomes of Deep Inspiration Breath-Hold (DIBH) Technique in Terms of Normal Tissue Sparing for Right-Sided Breast Cancer Irradiation: A Single-Institution Experience Cover

Dosimetric Outcomes of Deep Inspiration Breath-Hold (DIBH) Technique in Terms of Normal Tissue Sparing for Right-Sided Breast Cancer Irradiation: A Single-Institution Experience

Open Access
|Oct 2025

Figures & Tables

Summary of Target Volume Coverage in DIBH- or FB-Based Treatment Planning_

TARGET VOLUME COVERAGE DIBHFBABSOLUTE DIFFERENCERELATIVE DIFFERENCEp-VALUE
V95% (%)Median9797000.662492922
Range8888−0.6−0.621118012
99990.40.421052632
V90% (%)Median98.599.1−0.8−1.2048192770.139625473
Range9590.4−1.2−1.210898083
99.999.94.65.088495575

Summary of Dosimetric Findings of OAR Contralateral Lung between DIBH And FB Techniques of Irradiation_

CONTRALATERAL LUNG VARIABLES DIBHFBABSOLUTE DIFFERENCERELATIVE DIFFERENCEp-VALUE
Max dose (cGy)Median1578.451773−202.9−12.393979950.061554407
Range470.6460.3−875.9−34.09763314
2444.22741.8146.311.40655106
Mean dose (cGy)Median229.8321.85−63.75−20.523770120.032927742
Range3840.4−882.7−73.3505069
3421203.456.420.35366294

Summary of Dosimetric Findings of OAR ( Organ at Risk) Heart Between DIBH and FB Techniques of Irradiation_

HEART VARIABLES DIBHFBABSOLUTE DIFFERENCERELATIVE DIFFERENCEp-VALUE
Volume (ml)Median520.5537.9518.153.189361750.622128586
Range403.1381.1−1076.5−72.75615031
681.71479.6102.625.07331378
Mean dose (cGy)Median359.5472.15−78.1−17.489748060.000218629
Range79.797.4−235−43.63163758
75580522.417.63779528
V2 Gy (%)Median65.2580.45−10.3−12.850263380.024153571
Range17.3733.1−34.3−66.00782779
95.71004.14.475982533
V5 Gy (%)Median18.735.425−13.9−42.246164320.001596809
Range1.26.78−35.5−86.26609442
63.567.7−2.3−5.793450882
V10 Gy (%)Median0.7955.3−3.85−82.819935320.0001
Range00.26−11.83−100
23.527.411.622472.340426
V20 Gy (%)Median00000.193353996
Range00−8.83−100
2.739.660.1166.66666667
V25 Gy (%)Median00000.088106998
Range00−1.6−100
0.71.60.00114.28571429
Max dose (cGy)Median19872930.3−796.1−32.191243220.0003979580.05
Range663.71503.5−1309−55.85633522
26573706−607.7−28.30545062

Summary of Dosimetric Findings of OAR Contralateral Breast Between DIBH and FB Techniques of Irradiation_

CONTRALATERAL BREAST VARIABLES DIBHFBABSOLUTE DIFFERENCERELATIVE DIFFERENCEp-VALUE
Mean dose (cGy)Median306.35297.7−1.2−0.2832433560.284999874
Range31.926.8−148.6−49.30325149
448.2506.689.4101.6233766
V5 Gy (%)Median15.314.95−0.105−2.774594860.553793068
Range0.250.01−17.4−68.99696049
3236.515.92400

Summary of Dosimetric Findings of OAR Ipsilateral Lung between DIBH and FB Techniques of Irradiation_

IPSILATERAL LUNG VARIABLES DIBHFBABSOLUTE DIFFERENCERELATIVE DIFFERENCEp-VALUE
Volume (ml)Median1807.751005.95741.872.93396796<0.0001
Range951.9605.422.31.868610692
2234.113441216119.4381691
Mean dose (cGy)Median1191.41415.45−141.85−8.5297021090.010001072
Range774.1926.3−572.9−42.5315516
15871725.8503.253090436
V5 Gy (%)Median57.3572.85−11.89−17.91653481<0.0001
Range32.549.5−43.4−49.09502262
82.488.44.45.641025641
V16 Gy (%)Median21.26532.7−9.15−31.356424150.000397958
Range10.313.6−28.2−68.20987654
36.744.74.230.88235294
V20 Gy (%)Median19.31525.05−6.11−26.412223440.00111909
Range10.16.3−12.67−49.24623116
29.333.16.9109.5238095
Max dose (cGy)Median4012.654569.35−429.55−10.249672290.002666834
Range2924.63980.4−1401.8−31.27482082
5828.46184.840.099226037

Distribution of Patient and Treatment Characteristics_

CHARACTERISTICS NUMBERPERCENTAGE (%)
Clinical T stageT100
T2945
T3630
T4525
Clinical N stageN0420
N1525
N2735
N3420
Composite stageIIA315
IIB420
IIIA525
IIIB420
IIIC420
Type of surgeryMRM1890
BCS + ALND210
Presence of implantYes945
No1155
Nodal irradiationAxillary nodes1365
IMN nodes525
No nodal RT15
Radiation dose50 Gy in 25#1260
40 Gy in 15#840
Tumor bed boostYes210
No1890
Radiation techniqueVMAT1050
IMRT1050

Summary of Dosimetric Findings of OAR Liver Between DIBH and FB Techniques of Irradiation_

LIVER VARIABLES DIBHFBABSOLUTE DIFFERENCERELATIVE DIFFERENCEp-VALUE
Volume (ml)Median1462.21318.45153.89.5529073680.046760925
Range1066.91000.2−129.3−5.304615385
2308.22437.5402.831.8948452
Mean dose (cGy)Median271.65783.6−453.5−62.26498393<0.0001
Range54.8201.6−875.3−91.38674884
582.71344.7−146.8−38.69565217
Max dose (cGy)Median3952.354965.2−917.45−19.427254630.001022183
Range1081.62984.5−3590.7−72.77167525
5765.16217.6−28.3−0.713835288
V30 Gy Isodose (%)Median0.8853.405−2.48−68.820164670.00206989
Range00−8−100
4.7211.40.02200
V30 Gy Isodose (ml)Median16.67547.515−31.6−66.860108870.002253843
Range00−109.38−100
70.3179.680.3150
V10% isodose (%)Median15.5549.35−31.2−65.46855922<0.0001
Range0.014.02−727−99.75124378
35.4755.2−4.01−31.16062521
V10% isodose (ml)Median170.45578−357.3−64.1423338<0.0001
Range0.2571.3−1180.5−99.64936886
575.11280.16230.1305.1724138
V50% isodose (ml)Median31.7114.945−63.115−72.51538516<0.0001
Range09.7−242.4−100
120306.38.0883.29896907
V90% isodose (%)Median0.0450.625−0.285−89.949685530.000740489
Range00−4.02−100
0.974.500
V90% isodose (ml)Median0.67.955−3.9955−89.389402650.000775787
Range00−42.27−100
11.348.500
DOI: https://doi.org/10.2478/fco-2024-0016 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Submitted on: Apr 24, 2025
Accepted on: Jul 10, 2025
Published on: Oct 24, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2025 Raka Banerjee, Koustav Mazumder, Poonam Ray, Amitabh Ray, Sayan Kundu, Chandrani Mallik, Bodhisattwa Dutta, Dilip Kumar Ray, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

AHEAD OF PRINT